The diagnosis and treatment of patients with recurrent prostate cancer after radiotherapy is problematic in current clinical practice. Diagnostic possibilities for the detection of recurrences are limited. Further, conventional salvage techniques for the treatment of recurrences are known to have low chances of success and high toxicity rates. The various studies published in this thesis all serve the main research objective of improving the diagnosis and treatment of prostate cancer recurrences. It was investigated whether dynamic contrast enhanced (DCE-)MRI could serve as a diagnostic aid in the early detection of prostate cancer recurrences. Further, we investigated the theoretical possibility of a new salvage treatment strategy, focal s...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The clinical suspicion of local recurrence of prostate cancer (PCa) after radical prostatectomy (RP)...
Introduction: Whole-gland salvage treatment of radiorecurrent prostate cancer has a high rate of sev...
The diagnosis and treatment of patients with recurrent prostate cancer after radiotherapy is problem...
Prostate cancer (PCa) is frequently treated with radiotherapy. However, depending on the aggressiven...
Objective. To identify the possibility of multiparametrical magnetic resonance imaging (mpMRI) in th...
Over the last decades, primary prostate cancer radiotherapy saw improving developments, such as more...
Salvage radiotherapy for locally recurrent prostate cancer after primary radiation is generally perf...
Abstract Purpose To evaluate the value of dynamic contrast enhanced Magnetic Resonance Imaging (DCE-...
Background/Aim: Salvage radiotherapy improves biochemical control in patients with recurrence of pro...
The number of patients treated for prostate cancer by radiotherapy treatment has increased substanti...
Purpose: Evaluate T2 weighted MRI (T2W), diffusion weighted imaging (DWI), and dynamic contrast enha...
Aim: The aim of our study was to evaluate the sensitivity of contrast-enhanced magnetic resonance (C...
Only few patients with PSA relapse after radical treatment will show clinically detectable disease. ...
Patients primarily treated with radiotherapy for prostate cancer are at risk of recurrent disease. T...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The clinical suspicion of local recurrence of prostate cancer (PCa) after radical prostatectomy (RP)...
Introduction: Whole-gland salvage treatment of radiorecurrent prostate cancer has a high rate of sev...
The diagnosis and treatment of patients with recurrent prostate cancer after radiotherapy is problem...
Prostate cancer (PCa) is frequently treated with radiotherapy. However, depending on the aggressiven...
Objective. To identify the possibility of multiparametrical magnetic resonance imaging (mpMRI) in th...
Over the last decades, primary prostate cancer radiotherapy saw improving developments, such as more...
Salvage radiotherapy for locally recurrent prostate cancer after primary radiation is generally perf...
Abstract Purpose To evaluate the value of dynamic contrast enhanced Magnetic Resonance Imaging (DCE-...
Background/Aim: Salvage radiotherapy improves biochemical control in patients with recurrence of pro...
The number of patients treated for prostate cancer by radiotherapy treatment has increased substanti...
Purpose: Evaluate T2 weighted MRI (T2W), diffusion weighted imaging (DWI), and dynamic contrast enha...
Aim: The aim of our study was to evaluate the sensitivity of contrast-enhanced magnetic resonance (C...
Only few patients with PSA relapse after radical treatment will show clinically detectable disease. ...
Patients primarily treated with radiotherapy for prostate cancer are at risk of recurrent disease. T...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The clinical suspicion of local recurrence of prostate cancer (PCa) after radical prostatectomy (RP)...
Introduction: Whole-gland salvage treatment of radiorecurrent prostate cancer has a high rate of sev...